Viral Hepatitis
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2006; 12(4): 561-567
Published online Jan 28, 2006. doi: 10.3748/wjg.v12.i4.561
Table 3 Forward stepwise logistic regression analysis for all independent factors contributing to virological response
FactorsOdds ratio95% CIP
(At baseline)
HBV DNA less than 6.81434.7104.1 - 2000<  0.0001
HBeAg negativity7.1422.136 - 238.0< 0.0001
Platelet count more than 10 0x 109/L4.6251.242 - 17.220.0224
(During treatment)
Decline of HBV-DNA more than 3.2151.1311.21 - 233.0< 0.0001
within 3 mo of the start of treatment

  • Citation: Furusyo N, Takeoka H, Toyoda K, Murata M, Tanabe Y, Kajiwara E, Shimono J, Masumoto A, Maruyama T, Nomura H, Nakamuta M, Takahashi K, Shimoda S, Azuma K, Sakai H, Hayashi J, Group TKULDS. Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: A project of Kyushu University Liver Disease Study. World J Gastroenterol 2006; 12(4): 561-567
  • URL: https://www.wjgnet.com/1007-9327/full/v12/i4/561.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v12.i4.561